Targeted therapies that are designed to suppress the formation of new blood vessels in tumors, such as Avastin, have slowed cancer growth in some patients. However, they have not produced the dramatic responses researchers initially thought they might. Now, new research might help to explain the modest responses. The discovery suggests novel treatment combinations that could boost the power of therapies based on slowing blood vessel growth.